MPO and coronary artery disorder: All these conditions share similar pathophysiology in which inflammation plays a role (5) and many inflammatory biomarkers (e.g. C-reactive protein (CRP), interleukin(IL)-6, myeloperoxidase, soluble CD40 ligand, etc.)may have a potential role for predicting CAD or assessing the severity of CAD (6).